Obesity drugs like Ozempic and Wegovy are seen as major breakthroughs for those with chronic diseases like obesity and ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy ...

President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an ...

A startling moment unfolded at the White House when a man collapsed behind President Donald Trump during an Oval Office press ...

The White House’s weight-loss drug briefing was halted after Novo Nordisk executive Gordon Findlay fainted on camera, prompting an emergency response ...

Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Even after Trump’s new deal, obesity drugs are still too expensive.

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

The Trump administration is planning to release dietary guidelines in December aimed at reducing the high rates of obesity and other health issues in ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...